This highly instrumented laryngoscope measures intubation mechanics such as force and torque to quantitatively track how a laryngoscope is being inserted.
Stanford inventors have developed a method for collagen compression along with a polymer mesh as a mechanical support to produce collagen-based composite grafts.
Stanford inventors have engineered a method for breath-based cancer detection, which can provide rapid and non-invasive early cancer detection and surveillance.
Researchers at Stanford University, UCSB and MIT have invented a novel video compression pipeline, called Txt2Vid, which substantially reduces data transmission rates by compressing webcam videos ("talking-head videos") to a text transcript.
Inventors at Stanford University have developed a colorimetric device to visualize microstructural features in tissue biopsies towards clinical diagnostics.
Stanford inventors have developed a method of using CRISPR/Cas9 or similar gene editing technologies to genetically edit an individual's own myeloid cells for specific gene targets, which are critical to wound repair, and applying these edited cells in a hydrogel to promote ra
Researchers at Stanford have developed a method for targeted purification of megabase-sized extrachromosomal DNA (ecDNA) by combining in vitro nuclease treatment and pulsed field gel electrophoresis.
Researchers in Prof. David Myung's laboratory have developed a bio-compatible, crosslinking gel that can be used for in situ repair of damaged cornea or as a three-dimensional scaffold for keratocyte-keratinocyte tissue culture.
Stanford University researchers have developed a system that achieves atmospheric water harvesting with high specific productivity, defined as the rate of water collected per mass of absorbent material.
Stanford inventors have developed a novel method of using CD36 inhibitors to prevent and reduce skin scarring. They found that the protein JUN, a major driver of tissue scarring in many organs including the lung and skin, initiates fibrosis via CD36 in fibroblasts.
Using their newly developed acetyl-click screening platform, researchers at Stanford have identified riboflavin analogs as small molecule inhibitors of Histone Acetyltransferase 1 (HAT1) with anti-cancer activity.